World Health Organization : Year 2000 ; Communicable Diseases and Emerging Infectious Diseases ; Department of Control, Prevention, And Eradication, Strategy Development and Monitoring for Eradication and Elimination, No. 2000.15: Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis

By John Horton

Book Id: WPLBN0000168946
Format Type: PDF eBook:
File Size: 0.4 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 2000 ; Communicable Diseases and Emerging Infectious Diseases ; Department of Control, Prevention, And Eradication, Strategy Development and Monitoring for Eradication and Elimination, No. 2000.15: Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis
Author:	John Horton
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Horton, B. J. (n.d.). World Health Organization : Year 2000 ; Communicable Diseases and Emerging Infectious Diseases ; Department of Control, Prevention, And Eradication, Strategy Development and Monitoring for Eradication and Elimination, No. 2000.15. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
Lymphatic filariasis (LF) is a disabling, disfiguring infection caused by parasitic worms. It is estimated that 120 million people are infected in around 80 countries throughout the tropics and subtropics. Lymphatic filariasis is a major cause of disability, social stigmatization, psychosocial and economic reductions in life opportunities, and a major burden on health and hospital resources, especially on account of the costs for surgical intervention. The disease is a major contributor to poverty, and the programme to eliminate it will reduce suffering and disability, improve reproductive and sexual health (through reduced male genital morbidity) and will improve child and maternal health and development, through the ancillary benefits arising from effects on intestinal parasites. The programme will significantly contribute to reducing the numbers living in absolute poverty by 2015. Until recently, little could be done to relieve the suffering and disability caused by this disease. Today, however, significant advances have been made in understanding both the disease and its control. A global coalition has been forged among many organizations, each with a different mandate but all having a common goal: to tackle the wide-ranging and complex process of science, practice and management that will result in the elimination of LF as a public health problem* from the world. A strong start was made in 1997 when the World Health Assembly passed a resolution1 calling for ‘…the elimination of lymphatic filariasis as a public health problem…’*. Following this, WHO, with support from organizations including donor countries, the World Bank, the Arab Fund for Economic and Social Development, and the United States Centers for Disease Control and Prevention, began developing a coalition to eliminate the disease.

Table of Contents
T A B L E O F C O N T E N T S 1. INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.1 Make a commitment to the goal of lymphatic filariasis elimination . . . . . . . . . . . . . . . . . 2 1.2 Establish the National Task Force (NTF-ELF) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 1.3 Appoint a national programme manager/coordinator . . . . . . . . . . . . . . . . . . . . . . . . . . 3 2. SITUATION ANALYSIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-8 2.1 Designate the implementation unit (IU) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-8 2.2 Assess the distribution of infection and disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5-8 3. REVIEW AVAILABLE HUMAN RESOURCES AND INSTITUTIONAL LINKAGES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 3.1 Within the Ministry of Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 3.2 Other ministries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 3.3 Private sector . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 3.4 Identify the NGDOs which can collaborate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 3.5 Outside the country . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 4. ASSESS THE SOCIAL AND ECONOMIC IMPACT OF LYMPHATIC FILARIASIS, ESPECIALLY IN DEPRIVED COMMUNITIES . . . . . . . . . . . . . 11 5. DESIGN THE LF ELIMINATION STRATEGIES . . . . . . . . . . . . . . . . . . . . . . . . . 13 5.1 Plan for morbidity (disability) control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 5.2 Plan for interruption of LF transmission through mass drug administration . . . . . . . . . . 14-20 5.3 Integrate vector control measures with existing malaria and/or vector control training control programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 6. ESTIMATE DRUG REQUIREMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 6.1 Design drug procurement and distribution strategy and quality assurance . . . . . . . . . . . 21 6.2 Calculating requirements and procuring drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22-25